𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Canine chondrocytes seeded in type I and type II collagen implants investigated In Vitro

✍ Scribed by Nehrer, Stefan ;Breinan, Howard A. ;Ramappa, Arun ;Shortkroff, Sonya ;Young, Gretchen ;Minas, Tom ;Sledge, Clement B. ;Yannas, Ioannis V. ;Spector, Myron


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
469 KB
Volume
38
Category
Article
ISSN
0021-9304

No coin nor oath required. For personal study only.

✦ Synopsis


Synthetic and natural absorbable polymers have been used as vehicles for implantation of cells into cartilage defects to promote regeneration of the articular joint surface. Implants should provide a pore structure that allows cell adhesion and growth, and not provoke inflammation or toxicity when implanted in vivo. The scaffold should be absorbable and the degradation should match the rate of tissue regeneration. To facilitate cartilage repair the chemical structure and pore architecture of the matrix should allow the seeded cells to maintain the chondrocytic phenotype, characterized by synthesis of cartilage-specific proteins. We investigated the behavior of canine chondrocytes in two spongelike matrices in vitro: a collagen-glycosaminoglycan (GAG) copolymer produced from bovine hide consisting of type I collagen and a porous scaffold made of type II collagen by extraction of porcine cartilage. Canine chondrocytes were seeded on both types of matrices and cultured for 3 h, 7 days, and 14 days. The histology of chondrocyteseeded implants showed a significantly higher percentage of cells with spherical morphology, consistent with chondrocytic morphology, in the type II sponge at each time point. Pericellular matrix stained for proteoglycans and for type II collagen after 14 days. Biochemical analysis of the cell seeded sponges for GAG and DNA content showed increases with time. At day 14 there was a significantly higher amount of DNA and GAG in the type II matrix. This is the first study that directly compares the behavior of chondrocytes in type I and type II collagen matrices. The type II matrix may be of value as a vehicle for chondrocyte implantation on the basis of the higher percentage of chondrocytes retaining spherical morphology and greater biosynthetic activity that was reflected in the greater increase of GAG content.


πŸ“œ SIMILAR VOLUMES


Biosynthetic response of passaged chondr
✍ Lee, C. R. ;Grodzinsky, A. J. ;Spector, M. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

## Abstract To investigate the potential utility of mechanical loading in articular cartilage tissue engineering, porous type II collagen scaffolds seeded with adult canine passaged chondrocytes were subjected to static and dynamic compressions of varying magnitudes (0–50% static strain) and durati

Types I and III collagen in the tissue c
✍ Shannon, C. ;Thull, R. ;von Recum, A. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 158 KB πŸ‘ 2 views

Collagen plays an important role in wound healing and as such is present in connective tissue capsules around implanted materials. The proportion of type I collagen to type III collagen is lower during wound healing than that found in normal dermis, but the amount of type I collagen gradually increa

ESE-1 is a potent repressor of type II c
✍ Haibing Peng; Lujian Tan; Makoto Osaki; Yumei Zhan; Kosei Ijiri; Kaneyuki Tsuchi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 448 KB

## Abstract The epithelium‐specific ETS (ESE)‐1 transcription factor is induced in chondrocytes by interleukin‐1Ξ² (IL‐1Ξ²). We reported previously that early activation of EGR‐1 by IL‐1Ξ² results in suppression of the proximal __COL2A1__ promoter activity by displacement of Sp1 from GC boxes. Here we

Mutations in fibrillar collagens (types
✍ Helena Kuivaniemi; Gerard Tromp; Darwin J. Prockop πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 2 views

This review summarizes the data on 278 different mutations found to date in the genes for types I, II, III, IX, X, and XI collagens from 317 apparently unrelated patients. A majority (217 mutations; 78% of the total) of the mutations are single-base and either change the codon of a critical amino ac